Factors Affecting Mortality in Late Stage Parkinson’s Disease
Objective: To determine the effect of dysphagia and hospital admissions on mortality in late stage Parkinson's disease. Background: Parkinson’s disease (PD) is a neurodegenerative condition…Interleaving stimulation in Parkinson’s disease: interesting to whom?
Objective: Overview our patients’ experience with ILS and explore clinical scenarios in which ILS should be considered when programming DBS in PD patients. Background: Interleaving…The ultrasonographic assessment of vagus nerve atrophy comparison with autonomic dysfunction in Parkinson’s disease
Objective: To investigate the relationship between vagus nerve atrophy and clinical manifestation in Parkinson’s disease (PD). Background: PD is the progressive neurodegenerative disease and causes…Gray matter atrophy in Parkinson’s disease and freezing of gait assessed using surface-based algorithm – results of an open, longitudinal, single-centre study
Objective: The subsequent open, longitudinal study was performed to test whether grey matter (GM) atrophy and FOG severity changes over time and whether there is…Comorbid Parkinson’s disease and Myasthenia Gravis: A Case-Control Study
Objective: To evaluate the clinical features of patients with Parkinson’s Disease (PD) with versus without comorbid Myasthenia Gravis (MG). Background: The recognition of the co-occurrence…Repetitive transcranial magnetic stimulation can improve anxiety in Parkinson’s disease: a randomized, double-blind and controlled trial
Objective: High frequrncy (HF) repetitive transcranial magnetic stimulation (rTMS) improve anxiety in Parkinson’s Disease (PD). Background: The high frequency repetitive transcranial magnetic stimulation above the…Healthcare disparities in patients with Parkinson’s disease: A comprehensive literature review and call to action
Objective: To review the literature on healthcare disparities in Parkinson’s care in the United States and to initiate a community education program targeted at an…Deciphering the role of posttranslational modifications on α-synuclein aggregation and toxicity
Objective: The precise contribution of alpha-synuclein (ASYN) to neuronal dysfunction and death is still unclear. There is intense debate on the nature of the toxic…Braak model in Parkinson disease using MRI biomarkers
Objective: The aim of this study was to test using multimodal MRI biomarkers if the pattern of neurodegeneration in the brain of patients with PD…Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): An Update on Recruitment
Objective: To leverage technology to develop a new model for the long-term follow-up of Parkinson’s disease (PD) clinical trial cohorts and investigate novel disease measures.…
- « Previous Page
- 1
- …
- 126
- 127
- 128
- 129
- 130
- …
- 388
- Next Page »